The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.

NCT04065282 PHASE2 UNKNOWN

Sintilimab in Combination With Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant Therapy in patients With Resectable Locally Advanced Gastric Cancer

Details

Lead sponsor	First Affiliated Hospital of Zhejiang University
Phase	PHASE2
Status	UNKNOWN
Enrolment	36
Start date	Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Gastric Cancer

Interventions

• Sintilimab
• Oxaliplatin
• Capecitabine

Countries

China